Moreover, DOK7 gene therapy suppressed denervation at NMJs and enhanced motor activity and life span in a mouse model of familial amyotrophic lateral sclerosis (ALS), a fatal neuromuscular disease with motor neuron degeneration (Miyoshi et al., 2017). This evidence concerns the gene DOK7 and amyotrophic lateral sclerosis.